FlexifyMe, an innovative healthtech startup delivering AI-powered online physiotherapy, has raised $2.4 million in Pre-Series A funding. The round was led by IvyCap Ventures and Signal Ventures, providing the company with capital to scale its digital physiotherapy platform and bring personalized pain management to more patients worldwide.

Founded by Manjeet Singh, FlexifyMe is reimagining how people approach recovery, mobility, and pain relief - bringing physiotherapy directly to patients’ homes through a digital-first model.

---

What FlexifyMe Does

Physiotherapy is often seen as a critical yet underutilized aspect of healthcare. Millions of people suffer from chronic pain, musculoskeletal issues, and post-injury recovery needs but face barriers like accessibility, cost, and time.

FlexifyMe bridges this gap by offering online physiotherapy sessions designed by AI-certified physiotherapists. The platform creates personalized treatment plans that adapt to individual progress, combining medical expertise with digital tools to improve adherence and outcomes.

With a mission to “make pain-free living accessible to everyone,” FlexifyMe brings together AI-driven diagnostics, tailored therapy sessions, and continuous monitoring - all without requiring patients to travel to clinics.

---

Why This Funding Round Matters

The $2.4 million Pre-Series A funding will allow FlexifyMe to scale operations, expand its technology platform, and build partnerships with healthcare providers. For IvyCap Ventures and Signal Ventures, the investment reflects strong conviction in the future of tele-physiotherapy and digital therapeutics.

The problem FlexifyMe addresses is enormous. According to the World Health Organization (WHO), musculoskeletal conditions affect 1.71 billion people globally, making them the leading contributor to disability worldwide. Despite this, physiotherapy remains heavily under-penetrated, with millions of patients unable to access consistent, high-quality care.

FlexifyMe’s model aims to change this by making treatment both affordable and scalable.

---

Why It Matters Now

The timing of FlexifyMe’s growth couldn’t be more critical. Chronic pain, sedentary lifestyles, and post-COVID rehabilitation have all pushed demand for physiotherapy higher than ever. At the same time, patients are seeking digital-first solutions that fit seamlessly into their daily lives.

Research supports this growing opportunity:

• Precedence Research values the global physiotherapy market at $58 billion in 2022, projected to reach $122 billion by 2032, at a CAGR of 7.8%.
  
• Fortune Business Insights reports the global telehealth market hit $128 billion in 2022 and is expected to reach $504 billion by 2030, growing at a CAGR of 19.7%.
  
• A study in the Journal of Physiotherapy found that online physiotherapy interventions can be just as effective as in-person care for conditions like chronic knee and back pain.
  

This convergence of healthcare demand and digital adoption creates fertile ground for FlexifyMe’s expansion.

---

Hidden Insight for Founders

What makes FlexifyMe’s journey particularly relevant for founders is the way it reframes accessibility. Rather than competing with traditional physiotherapy clinics, FlexifyMe asked a different question: how can technology remove the barriers that prevent people from seeking care in the first place?

That’s the ultra value drop - true disruption doesn’t always mean replacing old systems; it often comes from unlocking access that was previously blocked. In healthcare, this means reaching patients who would otherwise never make it to a clinic due to distance, cost, or time.

For founders across industries, the lesson is powerful: when you identify the barriers that keep users from engaging, innovation lies not in building a better product for the few who already participate - but in expanding access to the many who don’t. FlexifyMe understood that the greatest growth doesn’t come from fighting incumbents head-on, but by opening doors that were previously closed.

---

Industry Outlook and Market Potential

FlexifyMe operates at the intersection of healthcare, digital therapeutics, and telemedicine - all high-growth sectors:

• Physiotherapy Market Growth: Projected to surpass $122 billion by 2032 (Precedence Research).
  
• Telehealth Expansion: Expected to grow nearly 4x in less than a decade, reaching $504 billion by 2030 (Fortune Business Insights).
  
• Digital Therapeutics: Valued at $6.2 billion in 2022, the digital therapeutics market is projected to hit $28 billion by 2030, at a CAGR of 20.5% (Grand View Research).
  
• Rising Chronic Pain Cases: According to the CDC, 1 in 5 adults in the U.S. suffers from chronic pain, underscoring massive demand for scalable pain management solutions.
  

These statistics highlight how FlexifyMe is positioned not only within an expanding market but also at the convergence of multiple industry megatrends.

---

What’s Next for FlexifyMe

With its Pre-Series A funding secured, FlexifyMe plans to:

• Expand its AI-powered platform to include more advanced diagnostics and therapy personalization.
  
• Grow its user base through partnerships with insurers, corporate wellness programs, and hospitals.
  
• Enhance patient engagement by integrating wearables and mobile health data for better monitoring.
  

The company’s long-term ambition is to make physiotherapy as accessible and routine as teleconsultations in general medicine - removing pain as a barrier to quality of life for millions.

If FlexifyMe succeeds, it could become a category leader in digital physiotherapy, bridging the gap between traditional healthcare delivery and the future of accessible, technology-driven care.